Lunan Pharmaceutical Group is a comprehensive pharmaceutical group integrating the production, scientific research and sales of medicine, chemicals and biological products. It is a national innovative enterprise and a key high-tech enterprise in the national torch plan. Its member enterprises are Lunan Houpu Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Shandong New Era Pharmaceutical Co., Ltd. and Lunan New Era Pharmaceutical Co., Ltd. ..
The group has a number of high-level R&D platforms, such as the National Chiral Pharmaceutical Engineering Technology Research Center, the National Engineering Laboratory for Efficient Expression of Mammalian Cells, the State Key Laboratory of Chinese Medicine Pharmaceutical Technology, and the National Enterprise Technology Center. It has established technical cooperation relations with more than 100 universities and research institutes at home and abroad, and the innovation ability of enterprise technology center ranks in the forefront of the national pharmaceutical industry.
Product strategy:
In the domestic market, we insist on "consolidating superior products and popularizing potential products" and implement the market development strategy, and product marketing presents a stable, sustained and healthy development trend. The annual sales of Xinkang series products and anti-cancer specific drug Weikangda have both exceeded 654.38+0 billion yuan; Lipid-lowering drug Ruizhi (rosuvastatin calcium) series products have broad market prospects, and it is estimated that the sales in 2-3 years will exceed 654.38+0 billion yuan.